|
Market Closed -
OTC Markets
23:50:25 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | +7.14% |
|
-18.92% | +15.38% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +7.14% | -18.92% | +20.00% | -20.00% | +15.38% | -86.37% | -95.63% | -99.41% | -99.53% | 7.42M | |
| +0.83% | +3.19% | +4.90% | -3.10% | +9.73% | +37.87% | +106.25% | +404.09% | +1,336.56% | 1,043B | |
| +1.93% | +2.11% | -2.11% | +0.90% | +26.33% | +36.82% | +64.90% | +62.46% | +119.26% | 618B | |
| +1.49% | +5.19% | +10.19% | +10.63% | +21.00% | +19.84% | +85.41% | +148.67% | +339.33% | 481B | |
| +2.26% | +0.90% | -1.31% | +16.41% | +38.32% | +66.40% | +39.33% | +80.58% | +131.96% | 351B | |
| +1.45% | +2.52% | +2.08% | +6.84% | +9.02% | +22.83% | +44.22% | -0.78% | +50.15% | 338B | |
| +1.17% | +0.88% | +6.53% | -5.40% | +8.67% | +11.83% | +34.76% | +55.48% | +55.58% | 269B | |
| +0.89% | -0.28% | +1.03% | -15.74% | -12.99% | -6.31% | +9.65% | +34.98% | +135.90% | 244B | |
| +1.82% | +2.94% | +6.03% | +14.09% | +26.75% | +40.43% | +52.78% | +98.55% | +147.68% | 220B | |
| +2.77% | +4.44% | +3.79% | +12.11% | +23.16% | +29.49% | +101.40% | +122.15% | +100.92% | 182B | |
| +2.14% | +2.10% | -12.59% | -21.01% | -21.52% | -33.60% | -60.44% | -19.25% | +88.86% | 166B | |
| +1.65% | +1.73% | +1.80% | +16.62% | +13.57% | +12.04% | -14.82% | -33.38% | -15.73% | 159B | |
| +1.36% | +1.06% | -2.12% | +2.74% | +12.51% | +22.95% | +43.60% | +185.06% | +495.19% | 128B | |
| -0.77% | -3.32% | -8.21% | +2.04% | +9.60% | +32.32% | +4.43% | +3.25% | +6.66% | 122B | |
| +0.92% | +4.05% | +5.29% | +18.42% | +14.45% | +23.86% | +107.81% | +368.95% | +466.18% | 108B | |
| +0.83% | +1.00% | -3.66% | -6.49% | -13.54% | -15.68% | -30.28% | -15.16% | +3.95% | 95.16B | |
| +0.84% | -2.51% | -2.59% | -11.59% | -4.08% | +7.99% | +16.71% | +0.07% | -18.08% | 91.9B | |
| +14.21% | +18.41% | +65.92% | +193.89% | +662.97% | +717.29% | +120.93% | -26.21% | - | 78.65B | |
| +0.94% | +1.54% | -7.57% | +11.77% | -3.28% | +30.99% | -10.25% | +35.73% | +91.39% | 73.85B | |
| +1.58% | +2.53% | +2.41% | -0.93% | +12.44% | +14.83% | -11.92% | -26.07% | +43.41% | 66.07B | |
| Average | +2.13% | -1.28% | +4.49% | +11.11% | +42.42% | +49.29% | +30.44% | +68.99% | +183.14% | 241.71B | |
| Weighted average by Cap. | +1.33% | +0.38% | +3.04% | +5.52% | +24.06% | +37.96% | +56.81% | +140.64% | +405.39% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
